Oncology Today with Dr Neil Love artwork

Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer

Oncology Today with Dr Neil Love

English - September 01, 2023 15:00 - 1 hour - 34.9 MB
Medicine Health & Fitness Science dr neil love research to practice oncology today oncology cme Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Role of BTK Inhibitors in Therapy for Mantle Cell Lymphoma
Next Episode: The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma

Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/HigherRiskProstate)

Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here